Related references
Note: Only part of the references are listed.Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinffi-piperaquine in patients with Plasmodium falciparum malaria in Thailand
J. Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Increased gametocytemia after treatment: An early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria
Karen I. Barnes et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
Petra F. Mens et al.
MALARIA JOURNAL (2008)
A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
Harin A. Karunajeewa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria
R. N. Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
World antimalarial resistance network I: Clinical efficacy of antimalarial drugs
Ric N. Price et al.
MALARIA JOURNAL (2007)
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites
Mallika Imwong et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Kasia Stepniewska et al.
MALARIA JOURNAL (2006)
Safety and efficacy of dihydroartemisinin/piperaquine (Artekin®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children
Corine Karema et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos)
M. Mayxay et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison
Frank Smithuis et al.
LANCET (2006)
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria
EA Ashley et al.
CLINICAL INFECTIOUS DISEASES (2005)
Piperaquine - A resurgent antimalarial drug
TME Davis et al.
DRUGS (2005)
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam:: randomised clinical trial
TT Hien et al.
LANCET (2004)
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand
EA Ashley et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria
CE Rwagacondo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Systematic reviews in health care -: Assessing the quality of controlled clinical trials
P Jüni et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
